bioRxivBiophysics
On The Use Of The Experimentally Determined Enzyme Inhibition Constant As A Measure Of Absolute Binding Affinity
Abstract
Defined as a state function representing an inhibitors absolute affinity for its target enzyme, the experimentally determined enzyme inhibition constant (Ki) is widely used to rank order binding affinities of different inhibitors for a common enzyme or different enzymes for a common inhibitor and to benchmark computational approaches to predicting binding affinity. Herein, we report that adsorption of bis(7)-tacrine to the glass container surface increased its Ki against Electrophorus electricus acetylcholinesterase (eeAChE) to 3.2 {+/-} 0.1 nM (n = 5) compared to 2.9 {+/-} 0.4 pM (n = 5) that was determined using plastic containers with other assay conditions kept the same. We also report that, due to binding or \"adsorption\" of bis(7)-tacrine to the inactive eeAChE, the bis(7)-tacrine Ki increased from 2.9 {+/-} 0.4 pM (n = 5) to 734 {+/-} 70 pM (n = 5) as the specific eeAChE activity decreased from 342 U/mg to 26 U/mg while other assay conditions were kept the same. These results caution against using Kis to rank order binding potencies, define selectivity, or benchmark computational methods without knowing detailed assay conditions.\n\nAbbreviations
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A two-point IC50 method for evaluating the biochemical potency of irreversible enzyme inhibitors
P. Kuzmic·bioRxiv·Jun 25, 2020
- Comparative Analysis of the Techniques for the Determination of Binding Affinity between a Small Molecule Inhibitor and a Protein Target
Yalan Luo, Yijun Chen·bioRxiv·May 16, 2024
- Deciding between one-step and two-step irreversible inhibition mechanisms on the basis of "kobs" data: A statistical approach
P. Kuzmic·bioRxiv·Jun 8, 2020
- Results of a large scale study of the binding of 50 type IIinhibitors to 348 kinases: The role of protein reorganization
Vardan H. Vardanyan, Allan Haldane, … Ronald M. Levy·Journal of Medicinal ChemistryPeer-reviewed·Apr 9, 2026
- Kinase inhibitors can change protonation or tautomeric state upon binding
Gehan Ranepura, Saqibul Islam Chowdhury, … M. R. Gunner·bioRxiv·Jul 30, 2026
- From Predicted Ki to Surrogate IC50: Similarity-Guided Empirical Calibration of Drug Target Affinity Predictions
Basel Mansour, Shayoni Dutta, … Dan Takahashi·bioRxiv·Sep 8, 2026